Fc gamma receptors are important components in the binding and phagocytosis of IgGsensitized cells. Studies on the role of these receptors have been limited by the fact that most hematopoietic cells express more than one Fc gamma receptor. We studied the role of Fc gamma RIIA in isolation on a human erythroleukemia cell line (HEL) which expresses Fc gamma RIIA as its only Fc gamma receptor. HEL cells were observed to bind and phagocytose IgG-sensitized red blood cells (RBCs) in a dose-dependent manner. We then examined the role of Fc gamma RI and Fc gamma RII in isolation and in combination, in transfected COS-1 cells. Fc gamma RIIA-transfected COS cells also mediated both the binding and phagocytosis of IgG-sensitized RBCs. In contrast, phagocytosis was not observed in Fc gamma RI-transfected cells, although these cells avidly bound IgGsensitized RBCs. Furthermore, coexpression of both receptors by doubly transfected cells did not affect the phagocytic efficiency of Fc gamma RIIA. These studies establish that Fc gamma RIIA can mediate phagocytosis and suggest that transfected COS-1 cells provide a model for examining this process. Since HEL cells exhibit characteristics of cells of the megakaryocyte-platelet lineage, including expression of Fc gamma RII as the only Fc gamma receptor, Fc gamma RIIA on megakaryocytes and platelets may be involved in the ingestion of IgG-containing immune complexes. […] Abstract Fc. receptors are important components in the binding and phagocytosis of IgG-sensitized cells. Studies on the role of these receptors have been limited by the fact that most hematopoietic cells express more than one Fc, receptor. We studied the role of Fc.YRIIA in isolation on a human erythroleukemia cell line (HEL) which expresses Fc.YRllA as its only Fc7 receptor. HEL cells were observed to bind and phagocytose IgG-sensitized red blood cells (RBCs) in a dose-dependent manner. We then examined the role of FcyRI and Fc.,RII in isolation and in combination, in transfected COS-1 cells. Fc.RIIA-transfected COS cells also mediated both the binding and phagocytosis of IgG-sensitized RBCs. In contrast, phagocytosis was not observed in Fc.RI-transfected cells, although these cells avidly bound IgG-sensitized RBCs. Furthermore, coexpression of both receptors by doubly transfected cells did not affect the phagocytic efficiency of FcRIIA. These studies establish that Fc.YRIIA can mediate phagocytosis and suggest that transfected COS-1 cells provide a model for examining this process. Since HEL cells exhibit characteristics of cells of the megakaryocyte-platelet lineage, including expression of FczRII as the only Fc.y receptor, Fc.RIIA on megakaryocytes and platelets may be involved in the ingestion of IgG-containing immune complexes. Furthermore, these studies indicate that Fc.RI and Fc.YRIIA differ in their requirements for transduction of a phagocytic signal. (J. Clin. Invest. 1991Invest. . 88:1766Invest. -1771 
Introduction
Hematopoietic cells express a wide range of surface molecules including those of the Fc.y receptor family (1) (2) (3) . These receptors are important in host defense because they represent a major mechanism for the detection and phagocytosis of such antibody-(IgG) sensitized cells as microorganisms. Six distinct genes which encode Fcz receptor proteins have been cloned.
These have been classified as FcYRI, FcRII (A, B, and C), and Fc.YRIII (A and B) (4) (5) (6) . These receptors are all members ofthe Ig gene superfamily and can be distinguished from each other by size, primary structure, ligand affinity, and MAb reactivity (7) (8) (9) . Although the extracellular Fcl-binding domains of the three receptors show considerable homology, the differences in the cytoplasmic domains suggest that they transmit different signals and subserve different functions. In this regard, although each of these Fcz receptor proteins is able to bind IgGcoated cells, the specific Fc.y receptor(s) responsible for phagocytosis is ill-defined.
Most hematopoietic cells, including phagocytic cells such as macrophages and granulocytes, express more than one Fc.y receptor protein (7) . Therefore, it has been difficult to define which Fcz receptor protein(s) is able to transduce a signal in the absence of a cooperative role from another class of Fcz receptor, using normal cells or cell lines. We used two approaches to address this issue. First, we studied the role of FcRII in human erythroleukemia (HEL) cells, a leukemic cell line that retains a number of features of the megakaryocyte-platelet lineage (10) . Like platelets-megakaryocytes, HEL cells express FcRII, primarily FcYRIIA as their only Fc, receptor class (King, M., P. G.
Comber, P. Chien, P. Ruiz, and A. D. Schreiber, manuscript submitted for publication) (11) (12) (13) . Second, by transfecting FcyRI and FcRIIA separately and together into COS-1 cells, a fibroblast-derived cell line lacking endogenous Fc., receptors, we were able to assess the properties of each receptor in a controlled manner. COS-1 cells were selected because of their efficiency oftransfection and because oftheir potential for mediating a phagocytic signal (14) . We were able to use these two approaches to determine whether Fc,,RIIA can mediate phagocytosis in isolation and to assess whether dual expression of receptors, in the case of doubly transfected COS-1 cells, affects individual Fcz receptor phagocytic function.
Methods
Cell culture and reagents. COS-1 cells were maintained in DME containing glucose (4.5 mg/ml), glutamine (25 mg/ml), penicillin (100 U/ ml), streptomycin (100 tig/ml), and 10% heat-inactivated FCS. 24 h before transfection cells were seeded onto 3.5-cm wells at a concentration of 3 X 105/well, in order for cells to reach -80% confluence for transfection. The HEL cell line was obtained from Dr. Eli Schwartz and Dr.
Mortimer Poncz (Children's Hospital of Philadelphia, Philadelphia, PA) and maintained in RPMI 160 medium (Gibco Laboratories, Grand Island, NY) supplemented with glutamine, penicillin, streptomycin, and FCS. Cell passages were performed approximately every 3 d and the cells were studied in the exponential phase of growth. Cytochalasin D (Sigma Chemical Co., St. Louis, MO) was dissolved in dimethylsulfoxide and diluted into culture medium to a concentration of 10 ,ug/ml. Both the anti-Fc.RII monoclonal antibody IV.3 (7) and the anti-FcXRI monoclonal antibody 32.2 (7) DEAE-dextran (400 ,g/ml), chloroquine chloride (100 ,M), and 250-500 ng plasmid DNA per 3.5 cm well. After 4 h at 370C, the transfection media was replaced with 10% DMSO in PBS for 2 min at room temperature. The cells were then washed and fresh media added for further incubation. Cells were harvested for analysis after 48 h. For these transfection studies we used p135, a plasmid containing fulllength human Fc7RI cDNA in CDM8, a vector utilizing the CMV promoter (15); and HFc 3.0, a plasmid containing full-length human FcRIIA in the SV40-based pKC4 vector (16) . p135 was the gift of Dr. Brian Seed (Massachusetts General Hospital, Boston, MA) and HFc 3.0 was the gift of Dr. P. Mark Hogarth (University of Melbourne, Melbourne, Australia).
Flow cytometry. Monoclonal antibodies directed against Fc.RII (MAb IV.3) and Fc.RI (MAb 32.2) (7) were used to assess receptor protein expression in transfected COS-I cells. Cell samples were incubated at 4°C with fluorescein-labeled MAb IV.3 and/or biotin-conjugated MAb 32.2. Biotin conjugates were stained with streptavidin-phycoerythrin. Isotype controls were employed for all reactions. Stained cells were fixed with 4% paraformaldehyde until analysis by flow cytometry. Fluorescence was measured on a FACStar (Becton-Dickinson, Mountainview, CA). For all samples 10,000 events were recorded on a logarithmetic fluorescence scale and mean fluorescence intensity data and contour maps generated using Consort 30 software. Anti-Fc.RI and anti-Fc.RII MAbs were employed following standardization with U-937 cells expressing a known quantity of Fc7RI and Fc.RII. U-937 expressed approximately 20,000-30,000 Fc.RI and 30,000-50,000 FcRII (17, 18) . U-937 cells stained with our streptavidin-phycoerythrin-biotin-anti-FcXRI have a shift of208 mean fluorescent intensity (MFI) units compared to an isotype control and a shift of 110 MFI units when stained with our FITC-anti-FcXRII.
Preparation ofIgG-sensitized red blood cells. Sheep red blood cells (RBCs) were sensitized with rabbit IgG anti-sheep RBC antibody as previously described (19) . In brief, for most experiments 109 sheep RBCs/ml (sterile sheep red blood cells; Rockland Inc., Gilbertsville, PA) in calcium and magnesium-free PBS/(PBS-) were sensitized by incubation with an equal volume of the highest subagglutinating concentration of rabbit anti-sheep RBC antibody (Cappel Laboratories, Cochranville, PA) at 37°C for 1 h. The IgG-sensitized sheep RBCs were washed twice, resuspended in PBSto a final concentration of 109 RBCs/ml and overlaid on transfected COS-1 cell or HEL cell monolayers.
Binding and phagocytosis of IgG-sensitized RBCs. Prior to each experiment HEL cells were harvested by sedimentation at 180 g and then washed three times with PBS5. 106 cells were incubated with IgGsensitized RBCs (EA) at 37°C and examined by light microscopy. Binding and phagocytosis of EA by COS-I cells and HEL cells were evaluated with RBCs sensitized with antibody dilutions from 1:250 through 1:8,000, as previously described (19) . COS-1 or HEL cells were incubated with washed EA at 37°C for 30 min. The unbound EA were removed by washing and the plates were stained with Wright-Giemsa.
At least 300 COSor HEL cells were examined by light microscopy and those cells binding five or more (EA) tallied in a blinded fashion. To assess phagocytosis, parallel groups ofcells were briefly exposed to a hypotonic solution to remove adherent EA. The cells were then stained with Wright-Giemsa and the number ofCOS-I or HEL cells with internalized EA were determined in a blinded fashion. Results were analyzed statistically by Student's t test.
Results
Binding of IgG-sensitized red blood cells by HEL cells. HEL cells, which express FcRII as their only Fc, receptor (King et al., submitted for publication), bound IgG-sensitized RBCs in a dose-dependant manner (Figs. 1 and 2 A). At 1:250 and 1:2,000 dilutions of antibody, 83 and 58% of HEL cells bound EA, respectively. Similar results were observed at 30, 60, and 120 min incubation of HEL cells with EA. Furthermore, the interaction was inhibited by anti-FcMRII antibody (P < 0.001) ( Fig. 1 ).
Expression ofFc, receptors in transfected COS-I cells. 48 h after transfection of COS-1 cells, cell surface-receptor expression was determined by FACSO analysis using biotin-conjugated anti-Fc7RI and/or fluoroscein-labeled anti-FcTRII. A fluorescence histogram of Fc.RI and Fc.RII individual transfectants is shown in Fig. 3 . Both receptors were efficiently expressed in transfected COS-l cells (MFR = 547 for Fc7RI transfectants and 266 for FcTRIIA transfectants, a relative difference similar to that observed for the expression of these receptors on U-937 cells). In the experiment shown in Fig. 4 , Binding of IgG-sensitized red blood cells by transfected COS-J cells. At high concentrations of IgG/RBC, COScells expressing transfected FcTRIIA and/or FcRI avidly bound opsonized sheep RBCs (Figs. 2 C and 5). There were no differences in binding capacity among different cell populations incubated with EA for 30, 60, or 120 min. We routinely observed that 35-48% of transfected cells bound EA (Fig. 5 ) and that most of these cells bound > 20 EA/cell. No binding was observed in mock transfected cells. With decreasing concentrations of IgG/RBC, the EA-binding capacity of FcMRIIA-transfected COS-1 cells fell rapidly. 40% of these transfected COS-I cells bound EA at a 1:250 dilution of antibody and 11% bound EA at an antibody dilution of 1:1,000. In contrast, a high percentage of Fc4R-transfected cells retained the capacity to bind large numbers of EA even at very low concentrations of IgG/ RBC (e.g., 30% of COS-I cells bound EA at a 1:4,000 antibody dilution). Cell populations doubly transfected with Fc4U and Fc7RIIA were similar to Fc.,RI-transfected cells in that they 370C with EA and stained with Wright-Giemsa after hypotonic lysis of externally bound EA. 16-19% of HEL cells phagocytosed EA following 30, 60 and 120 min incubation with EA at 370C ( Figs. 1 and 2 B ). The variation in intracellular degradation of EA by HEL cells made accurate assessment ofthe extent ofphagocytosis difficult after prolonged incubation. Therefore, phagocytosis was assessed after 30 min ofHEL cell-EA incubation. Cytochalasin D, a reagent which inhibits actin polymerization, completely abrogated phagocytosis (P < 0.001) and preincubation of HEL cells with anti-Fc.,RII MAb significantly (P < 0.001) reduced phagocytosis from 17 to 1% (Fig. 1) .
No phagocytosis was observed in FcYRI-transfected populations of COS-1 cells even at high concentrations of IgG/RBC after 30, 60, or 120 min incubations with EA, even though these cells bound large numbers of EA externally. In contrast, at high concentrations of IgG/RBC (1:250 and .1:500 antibody dilutions) phagocytosis of EA proceeded rapidly in cell populations expressing Fc.RIIA. 12-20% ofFc7RIIA-transfected cells contained ingested RBCs after 30 min ofincubation with EA at 370C (Figs. 5 and 2 D). There was a decrease in the number of cells containing ingested RBCs after 1 or 2 h ofincubation with EA, and both empty vacuoles and vacuoles containing partially digested RBCs were observed at that time. There was no evidence of phagocytosis in Fc7RIIA-transfected cells incubated with EA at 00C for 30 min or in cells incubated in the presence of cytochalasin D. The ability of FcYRIIA-transfected cells to phagocytose EA was clearly dependent on IgG concentration. Phagocytosis fell rapidly at antibody dilutions > 1:500 (< 1% ofcells internalized EA at > 1:1,000 antibody dilutions), paralleling the decreased ability of these cells to bind EA at these antibody concentrations. High concentrations of IgG/RBC were also required for phagocytosis ofEA in cells doubly transfected with FcXRI and FcXRIIA (9-16% phagocytic cells). There was no evidence that coexpression of Fc.RI mediated an increase in phagocytosis at any IgG antibody concentration.
Discussion
Since Fc, receptor-expressing cells such as monocytes, macrophages, and granulocytes express more than one class of FcR ( 1-3) , it is difficult to assess whether one Fc, receptor class can mediate a phagocytic signal without the influence of another. Most previous studies have utilized complexes ofindividual IgG subclasses or specific MAbs as probes for phagocytosis. These reagents do not permit complete discrimination between individual Fc, receptor classes. For example, the affinity of Fc, receptors for individual IgG isotypes is relative rather than absolute. Similarly, the affinity of MAb for Fc, receptor epitopes may not allow for complete inhibition of IgG ligand binding. In addition, these reagents do not address the possibility of interactions between Fc, receptors that involve domains other than those in the extracellular region. For example, activation of Fc, receptors by ligand or antibody binding may result in a signal which involves the transmembrane or cytosolic domain of other Fc, receptor classes.
To study the role of FcXRII in isolation, we first examined Fc7 receptor function in the human erythroleukemia cell line HEL. This cell line was previously demonstrated to express a number of markers characteristic of cells of the megakaryocyte-platelet lineage including alpha-granule proteins, glycoproteins Ib, IIb/IIIa and the platelet alloantigen PI'A (10) . In addition, HEL cells under certain conditions were shown to bind IgG-sensitized cells (20) , suggesting the presence of Fc, receptors. In a previous study we used a panel of monoclonal antibodies directed at epitopes specific for each of the three classes of human Fc7 receptors, as well as Northern blot and PCR analysis, to establish that Fc.,RII (predominantly .-I Fc., receptors. We have also observed that a high affinity MAb that competes for the FczRII ligand binding site (5, 7, 15) inhibits this process (Fig. 1 ). We then introduced individual Fcz receptors by transient transfection into a cell line lacking endogenous Fcz receptors to establish an approach for studying individual Fc7 receptor function and interaction. Transfection of cDNAs encoding human FczRI and Fc7RIIA into COS-1 cells was an efficient means of obtaining cells that express individual Fc.y receptors.
As measured by FACS analysis, 25-48% oftransfected cell populations expressed these receptors. Thus, we were able to study binding and phagocytosis of IgG-sensitized erythrocytes by FczRI and Fc.YRIIA, individually and paired, under controlled conditions. Only COS-I cells expressing Fc7RIIA could phagocytose IgG-sensitized erythrocytes. Ingestion by Fc7RIIA transfectants occurred only with high concentrations of IgG per RBC. In contrast, FczRI transfectants were unable to mediate phagocytosis at any concentration of IgG per RBC examined. In addition, since no difference in the pattern of efficiency of phagocytosis was observed in doubly-transfected cells, it appears that in COS-1 cells coexpression of FczRI and Fc.RIIA does not influence the process of phagocytosis by Fc.YRIIA.
The inability of FczRI on COS-1 cells to mediate a phagocytic signal after binding EA may relate to intrinsic differences in the FcRI and FczRIIA receptors. There are data that indicate that both FczRI and Fc7RII on other cells are able to phagocytose EA (21) . While COS-1 cells may lack the necessary accessory molecules to allow phagocytosis by Fc7RI, they possess the elements necessary for Fc.RII-mediated phagocytosis. Our studies, therefore, suggest that Fc.YRI and FcYRIIA differ in their requirements for transmission of a phagocytic signal.
Since the isolation of the receptor proteins and their genes (3) (4) (5) (6) (7) (8) (9) , the functional role of human Fc, receptors has been the focus of investigation in several cell systems. The data concerning the role of the three human Fcz receptors is conflicting. There are data using MAbs that show that hematopoietic cells are able to phagocytose ox RBCs by Fc7RI and Fc7RII (21) . However, a similar approach demonstrated that phagocytosis of tumor cells by cultured monocytes was mediated by Fc7RII and Fc.RIII, but not Fc7RI (22) . Our studies indicate that phagocytosis in a transfected COS-1 cell is mediated by Fc.,RIIA, but not Fc.,RI. (25) . Because their monocytes were able to mediate phagocytosis ofEA that was inhibited by anti-FcRII, it was suggested that FczRII can mediate phagocytosis of IgG-sensitized cells in the absence of other Fc.y receptors. However, it is uncertain whether the monocytes of these patients express FcYRI mRNA and/or low levels of the high affinity FczRI protein. Furthermore, there are data that indicate that monocytes express low levels of Fc7RIII (26), which might contribute to phagocytosis in these patients. Studies in human subjects suggest that FcIRIII is involved in the clearance of IgG-sensitized cells in autoimmune disease (27, 28) .
We observed that COS-1 cells transfected with Fc7RI are able to bind RBCs sensitized with considerably lower concentrations of IgG antibody than COS-1 cells transfected with Fc.RIIA. This likely reflects the increased affinity of Fc4U for monomeric and complexed IgG (5, 7, 15 These studies imply that both COS-l cells and HEL cells may serve as models for the study of individual human receptor functions. Our studies also suggest that these cells have potential value for the examination ofphagocytic mechanisms.
As with phagocytosis in hematopoietic cells, ingestion ofRBCs required an intact cytoskeleton, as indicated by sensitivity to cytochalasin D. Furthermore, we observed that both transfected COS-1 cells and HEL cells were not only able to phagocytose IgG-sensitized cells by Fc.RIIA, but also appeared able to degrade EA within vacuole-like structures. Thus, COS-1 cells, a cell line derived from monkey kidney fibroblasts, and HEL cells, which have properties common to cells ofthe megakaryocyte/platelet lineage, may serve as models for understanding postphagocytic events and intracellular properties of hematopoietic cells.
